Put a2m in the bottom draw and leave it there until August earnings. Sediment has not changed in this company structure, grow is inevitable. Expansion in china, UK, USA and consistent support from our local Australian and New Zealand community will be proven in time.
How can one value the share price to be worth under $1.50 currently when it was well past this figure on the fy16 forecast in December 2015 with revenue to be predicted to be 285 million?
With august earnings suggesting that a predicted revenue of 335 to 350 million will be achieved, how can one not see undervaluation at the current price?
Psychologically I know you may feel the pressure of the red but why sell now when we sat a consistent datum of around $1.70 for months?
I'm usually one to observe but I cannot ignore these short littered threads to get inside the retails heads.
Shorts will only make money if you sell your shares at ridiculous bargains and obviously they have identified a good opportunity with apparent Chinese regulation changes, although regulation changes hardly have an impact at this point in time.
The company has a product that can’t be duplicated rapidly by opposition, so why would consumer surplus diminish any time soon?
Holding since 99 cents and holding for years to come.
All in my opinion, happy to hear your point of view.
- Forums
- ASX - By Stock
- A2M
- Starve the shorts
Starve the shorts
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.82 |
Change
-0.100(2.03%) |
Mkt cap ! $3.489B |
Open | High | Low | Value | Volume |
$4.95 | $4.95 | $4.77 | $31.51M | 6.542M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3831 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.82 | 252136 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3831 | 4.810 |
2 | 4260 | 4.800 |
2 | 6100 | 4.790 |
5 | 31763 | 4.780 |
4 | 29250 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.820 | 252136 | 2 |
4.830 | 25742 | 4 |
4.840 | 5000 | 1 |
4.850 | 268495 | 4 |
4.860 | 118035 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online